ctrl K

Watchlist Price Alert

Drugs Made In America Acq... (DMAA)

NASDAQ: DMAA · Real-Time Price · USD

10.10

0.00 (0.00%)

At close: May 07, 2025, 2:21 PM

Drugs Made In America Acquisition Ordinary Shares Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash & Equivalents	1.35	2.1K	18.10
Short-Term Investments	1.35K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	545.83	424.04K	112.96
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a
Total Current Assets	4.99K	2.1K	78.10
Property-Plant & Equipment	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	545.83	424.04K	112.96
Total Assets	550.82	426.14K	191.06
Account Payables	n/a	n/a	n/a
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	662.32	552.01K	210.09
Other Current Liabilities	56.06	38.98K	0.90
Total Current Liabilities	795.67	591K	210.99
Long-Term Debt	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a
Total Liabilities	795.67	591K	210.99
Total Debt	662.32	552.01K	210.09
Common Stock	986.00	986.00	0.99
Retained Earnings	-279.85	-199.86K	-54.93
Comprehensive Income	n/a	n/a	-0.00
Shareholders Equity	-244.84	-164.86K	-19.93
Total Investments	1.35K	n/a	n/a